twitter
en ENGLISH
eISSN: 2719-3209
ISSN: 0023-2157
Klinika Oczna / Acta Ophthalmologica Polonica
Bieżący numer Archiwum Filmy Artykuły w druku O czasopiśmie Suplementy Rada naukowa Recenzenci Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Standardy etyczne i procedury
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
SCImago Journal & Country Rank
2/2022
vol. 124
 
Poleć ten artykuł:
Udostępnij:
streszczenie artykułu:
Artykuł przeglądowy

Zastosowanie cyklopentolatu w okulistyce

Anna Chmielarz-Czarnocińska
1
,
Anna Gotz-Więckowska
1

1.
Department of Ophthalmology, Chair of Ophthalmology and Optometry, Poznan University of Medical Sciences, Poznan, Poland
KLINIKA OCZNA 2022; 124, 2: 71-74
Data publikacji online: 2022/06/14
Pełna treść artykułu Pobierz cytowanie
 
Metryki PlumX:


Cyclopentolate is a drug that causes paralysis of accommodation and induces mydriasis. It is widely used around the world. In view of its relatively short duration of action and effective induction of cycloplegia, cyclopentolate is particularly useful in screening children for refractive errors. In addition to diagnostic applications, it is also used for therapeutic purposes, e.g. in uveitis. In October 2021, cyclopentolate, which had not been approved in Poland for years, was authorized for marketing.

The authors of the paper reviewed the literature on cyclopentolate. The properties of the drug were analyzed, and its action was compared with other available cycloplegic agents. In addition, the potential uses of cyclopentolate and its special role in facilitating the ophthalmological examination of children were discussed.
© 2024 Termedia Sp. z o.o.
Developed by Bentus.